Novel sp3-rich amine and heterocyclic compounds for antimycobacterial drug discovery

Overview

This offering provides access to a synthetic chemistry pipeline focused on novel amine, benzylamine, and carboxylic acid intermediates designed for antimycobacterial drug discovery. The work centers on inhibiting mycobacterial targets through structure–activity relationship (SAR) exploration of heterocycles and pendant amines. A distinguishing capability is the production of sp3-rich cyclohexyl-bearing compounds accessed through C–H activation chemistry, which represents a new direction beyond conventional flat-molecule synthesis.

Technical specifications

Core synthetic capabilities:

• Preparation of novel amines from nitro precursors
• Synthesis of benzylamines from nitrile starting materials
• Generation of carboxylic acids from ester precursors
• C–H activation routes to sp3-rich cyclohexyl intermediates
• Flexible analog generation to support systematic SAR studies

Compound features:

• Emphasis on three-dimensional, sp3-rich scaffolds to expand chemical diversity beyond flat aromatic systems
• Heterocyclic cores paired with pendant amine functionality tailored to mycobacterial target engagement

Technology readiness level

The amine, benzylamine, and carboxylic acid syntheses represent established, routinely practiced routes enabling rapid analog preparation. The C–H activation chemistry yielding sp3-rich cyclohexyl compounds is newly initiated and at an early exploratory stage, offering a novel but emerging direction for collaborative development and validation.